ANTABUSE TAB 0.25GM DIN 00002534
Health Canada record
| Active ingredient(s) | DISULFIRAM 250 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N07BB01 DISULFIRAM |
| Original market date | 31-Dec-1966 |
| Current status date | 10-Sep-1996 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DISULFIRAM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02041375 | ANTABUSE TAB 250MG | WYETH-AYERST CANADA INC. | Tablet | DISULFIRAM 250 MG | Cancelled Post Market |
| 02041391 | ANTABUSE TAB 500MG | WYETH-AYERST CANADA INC. | Tablet | DISULFIRAM 500 MG | Cancelled Post Market |
International API supply for DISULFIRAM
1 valid EDQM Certificates of Suitability from 1 holders. 3 active FDA Drug Master Files.
Request a quote for ANTABUSE TAB 0.25GM